Veracyte Inc (VCYT US)

Analysis

Health Care • United States

Veracyte, Inc. develops molecular tests for oncology. The Company offers molecular cytology and tests for the diagnostic accuracy of cytology samples. Veracyte provides its products and services to healthcare and molecular diagnostic companies in the United States.

Refresh

Company Presentation • 31 Jul 2026 04:30

Q2 2026

Company Presentation • 03 Jun 2026 03:00

46th Annual William Blair Growth Stock Conference

Company Presentation • 01 Jun 2026 20:30

Study update

Company Presentation • 06 May 2026 04:30

Q1 2026

Company Presentation • 03 Mar 2026 21:05

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Q2 2026

46th Annual William Blair Growth Stock Conference

Study update

Q1 2026

47th Annual Raymond James Institutional Investor Conference